Health care and tech innovation go hand in hand. From delivering steady streams of medication to speeding up treatment of ...

DGX exhibits strength in its base business. Increasing utilization of the Advanced Diagnostics offering is another positive.

Following my cortisol blood test, I've spoken with several doctors to better understand my "high cortisol" results and answer ...

On Friday, Quest Diagnostics Inc (DGX) stock saw a modest uptick, ending the day at $160.44 which represents a slight increase of $3.60 or 2.30% from the prior close of $156.84. The stock opened at ...

Apollon Wealth Management LLC lowered its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 10.4% ...

Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The test will measure levels of the 14-3-3eta protein, which is used in the diagnosis and management of inflammatory diseases including rheumatoid arthritis.

Shares of DGX opened at $160.17 on Friday. Quest Diagnostics has a 1 year low of $123.04 and a 1 year high of $162.48. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.25 and a ...

By combining ExamOne’s expertise in records retrieval with DigitalOwl’s advanced AI-driven analysis capabilities, clients can expect an enhanced overall workflow, reduced processing times, and ...

Laboratory services provider Labcorp (LH) announced Tuesday that Executive Vice President and Chief Financial Officer (CFO) Glenn ...